Tom Stargardt

Cited by

	All	Since 2018
Citations	4273	2445
h-index	34	25
i10-index	60	48

820

410

205

615

20062007200820092010201120122013201420152016201720182019202020212022202320 22 58 61 100 153 244 207 230 242 218 225 238 200 293 746 810 147

Public access

View all

19 articles

4 articles

available

not available

Based on funding mandates

Co-authors

Jonas SchreyöggProfessor für Management im Gesundheitswesen, Universität HamburgVerified email at uni-hamburg.de
Reinhard BusseProfessor für Management im Gesundheitswesen, Technische Universität BerlinVerified email at tu-berlin.de
Pedro Pita BarrosProfessor of Economics, Nova School of Business and Economics, Universidade Nova de LisboaVerified email at novasbe.pt
Iryna SabatNova School of Business and EconomicsVerified email at novasbe.pt
Sebastian Neumann-BöhmeHamburg Center for Health Economics, University of HamburgVerified email at uni-hamburg.de
Job van ExelErasmus University RotterdamVerified email at eshpm.eur.nl
Werner B.F. BrouwerProfessor of Health Economics, Erasmus School of Health Policy & Management, Erasmus UniversityVerified email at eshpm.eur.nl
Carl Rudolf BlankartProfessor of Regulatory Affairs, KPM Center of Public Management, University of BernVerified email at kpm.unibe.ch
Katharina E Blankart (nee Fischer)University of Duisburg-Essen / CINCH Health Economics Research CenterVerified email at uni-due.de
Christian GerickeWesley Research Institute/ University of Queensland / Queensland University of Technology Verified email at uq.edu.au
Dr. Simon FreyRoche Pharma AGVerified email at roche.com
Aleksandra TorbicaUniversità Commerciale Luigi BocconiVerified email at unibocconi.it
Sotiris VandorosKing's College London and Harvard UniversityVerified email at kcl.ac.uk
Frans RuttenProfessor of Health EconomicsVerified email at bmg.eur.nl
Prof. Dr. André HajekUniversity Medical Center Hamburg-Eppendorf, Department of Health Economics and Health ServicesVerified email at uke.de
Ivan KondoferskyPostDoc TU Munich and Helmholtz Zentrum MunichVerified email at helmholtz-muenchen.de
Carsten SchultzKiel UniversityVerified email at bwl.uni-kiel.de

Tom Stargardt

Professor for Health Care Management

Verified email at uni-hamburg.de - Homepage

Health Economic Evaluation Pharmaceutical Regulation Health Services Research


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19 S Neumann-Böhme, NE Varghese, I Sabat, PP Barros, W Brouwer, ... The European Journal of Health Economics 21, 977-982, 2020	896	2020
Methods to determine reimbursement rates for diagnosis related groups (DRG): a comparison of nine European countries J Schreyögg, T Stargardt, O Tiemann, R Busse Health Care Management Science 9 (3), 215-223, 2006	299	2006
Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches AK Buck, K Herrmann, T Stargardt, T Dechow, BJ Krause, J Schreyögg Journal of nuclear medicine technology 38 (1), 6-17, 2010	245	2010
Management im Gesundheitswesen: Das Lehrbuch für Studium und Praxis R Busse, J Schreyögg, T Stargardt Springer-Verlag, 2017	213*	2017
United but divided: Policy responses and people’s perceptions in the EU during the COVID-19 outbreak I Sabat, S Neumann-Böhme, NE Varghese, PP Barros, W Brouwer, ... Health Policy 124 (9), 909-918, 2020	185	2020
Reforms in the Greek pharmaceutical market during the financial crisis S Vandoros, T Stargardt Health policy 109 (1), 1-6, 2013	127	2013
Defining the “Health Benefit Basket” in nine European countries J Schreyögg, T Stargardt, M Velasco-Garrido, R Busse The European Journal of Health Economics 6, 2-10, 2005	127	2005
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment M Drummond, B Jönsson, F Rutten, T Stargardt The European Journal of Health Economics 12 (3), 263-271, 2011	113	2011
Health service costs in Europe: cost and reimbursement of primary hip replacement in nine countries T Stargardt Health economics 17 (S1), S9-S20, 2008	111	2008
Availability of and Access to Orphan Drugs CR Blankart, T Stargardt, J Schreyögg Pharmacoeconomics 29 (1), 63-82, 2011	91	2011
Patient‐reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: associations with hypoglycaemia and weight gain E Marrett, T Stargardt, P Mavros, CM Alexander Diabetes, obesity and metabolism 11 (12), 1138-1144, 2009	89	2009
Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes T Stargardt, L Gonder-Frederick, KJ Krobot, CM Alexander Health Qual Life Outcomes 7, 91, 2009	85	2009
Impact of Cross-Reference Pricing on Pharmaceutical Prices: Manufacturers Pricing Strategies and Price Regulation T Stargardt, J Schreyogg Applied Health Economics and Health Policy 5 (4), 235-247, 2006	85	2006
Cost-effectiveness of hybrid PET/CT for staging of non–small cell lung cancer J Schreyögg, J Weller, T Stargardt, K Herrmann, C Bluemel, T Dechow, ... Journal of Nuclear Medicine 51 (11), 1668-1675, 2010	74	2010
Drug prescription patterns in schizophrenia outpatients: analysis of data from a German health insurance fund S Weinbrenner, HJ Assion, T Stargardt, R Busse, G Juckel, CA Gericke Pharmacopsychiatry 42 (2), 66, 2009	73	2009
The Trade‐Off between Costs and Outcomes: The Case of Acute Myocardial Infarction J Schreyögg, T Stargardt Health Services Research 45 (6p1), 1585-1601, 2010	62	2010
The impact of reference pricing on switching behaviour and healthcare utilisation: the case of statins in Germany T Stargardt The European Journal of Health Economics 11 (3), 267-277, 2010	62	2010
Costs and quality of hospitals in different health care systems: a multi‐level approach with propensity score matching J Schreyögg, T Stargardt, O Tiemann Health Economics 20 (1), 85-100, 2011	61	2011
Effect of Type of Insurance and Income on Waiting Time for Outpatient Care K Roll, T Stargardt, J Schreyögg The Geneva Papers on Risk and Insurance-Issues and Practice, 2012	53	2012
Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and Australia KE Fischer, T Heisser, T Stargardt Health Policy 120 (10), 1115-1122, 2016	50	2016

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors